100 related articles for article (PubMed ID: 7903201)
1. Allelotype analysis of mouse skin tumors using polymorphic microsatellites: sequential genetic alterations on chromosomes 6, 7, and 11.
Kemp CJ; Fee F; Balmain A
Cancer Res; 1993 Dec; 53(24):6022-7. PubMed ID: 7903201
[TBL] [Abstract][Full Text] [Related]
2. Allelotype analysis of chemically induced squamous cell carcinomas in F(1) hybrids of two inbred mouse strains with different susceptibility to tumor progression.
Stern MC; Benavides F; Klingelberger EA; Conti CJ
Carcinogenesis; 2000 Jul; 21(7):1297-301. PubMed ID: 10874006
[TBL] [Abstract][Full Text] [Related]
3. Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas.
Dodson MK; Hartmann LC; Cliby WA; DeLacey KA; Keeney GL; Ritland SR; Su JQ; Podratz KC; Jenkins RB
Cancer Res; 1993 Oct; 53(19):4456-60. PubMed ID: 8402612
[TBL] [Abstract][Full Text] [Related]
4. Oncogene activation and tumor suppressor gene inactivation during multistage mouse skin carcinogenesis.
Bowden GT; Schneider B; Domann R; Kulesz-Martin M
Cancer Res; 1994 Apr; 54(7 Suppl):1882s-1885s. PubMed ID: 8137304
[TBL] [Abstract][Full Text] [Related]
5. [Genetic alterations in the region of the p53 gene on human chromosome 17 in colorectal cancer].
Kashkin KN; Fleĭshman EV; Chumakov PM; Perevoshchikov AG
Genetika; 1998 Aug; 34(8):1049-55. PubMed ID: 9777351
[TBL] [Abstract][Full Text] [Related]
6. Allelic loss mapping and physical delineation of a region harboring a putative thymic lymphoma suppressor gene on mouse chromosome 12.
Shinbo T; Matsuki A; Matsumoto Y; Kosugi S; Takahashi Y; Niwa O; Kominami R
Oncogene; 1999 Jul; 18(28):4131-6. PubMed ID: 10435594
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide screen for allelic imbalance in a mouse model for neuroblastoma.
Weiss WA; Godfrey T; Francisco C; Bishop JM
Cancer Res; 2000 May; 60(9):2483-7. PubMed ID: 10811128
[TBL] [Abstract][Full Text] [Related]
8. Allelotype analysis of mouse lung carcinomas reveals frequent allelic losses on chromosome 4 and an association between allelic imbalances on chromosome 6 and K-ras activation.
Hegi ME; Devereux TR; Dietrich WF; Cochran CJ; Lander ES; Foley JF; Maronpot RR; Anderson MW; Wiseman RW
Cancer Res; 1994 Dec; 54(23):6257-64. PubMed ID: 7954475
[TBL] [Abstract][Full Text] [Related]
9. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
[TBL] [Abstract][Full Text] [Related]
10. Basal cell carcinomas and squamous cell carcinomas of human skin show distinct patterns of chromosome loss.
Quinn AG; Sikkink S; Rees JL
Cancer Res; 1994 Sep; 54(17):4756-9. PubMed ID: 8062275
[TBL] [Abstract][Full Text] [Related]
11. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology.
Thrash-Bingham CA; Salazar H; Freed JJ; Greenberg RE; Tartof KD
Cancer Res; 1995 Dec; 55(24):6189-95. PubMed ID: 8521412
[TBL] [Abstract][Full Text] [Related]
12. Loss of heterozygosity on chromosomes 1, 11, 12, and 14 in hybrid mouse lung adenocarcinomas.
Herzog CR; Chen B; Wang Y; Schut HA; You M
Mol Carcinog; 1996 Jun; 16(2):83-90. PubMed ID: 8645430
[TBL] [Abstract][Full Text] [Related]
13. Allelic imbalance in mammary carcinomas induced by either 7,12-dimethylbenz[a]anthracene or ionizing radiation in rats carrying genes conferring differential susceptibilities to mammary carcinogenesis.
Haag JD; Hsu LC; Newton MA; Gould MN
Mol Carcinog; 1996 Nov; 17(3):134-43. PubMed ID: 8944073
[TBL] [Abstract][Full Text] [Related]
14. Genomic alterations in cervical carcinoma: losses of chromosome heterozygosity and human papilloma virus tumor status.
Mullokandov MR; Kholodilov NG; Atkin NB; Burk RD; Johnson AB; Klinger HP
Cancer Res; 1996 Jan; 56(1):197-205. PubMed ID: 8548763
[TBL] [Abstract][Full Text] [Related]
15. Allele-specific Hras mutations and genetic alterations at tumor susceptibility loci in skin carcinomas from interspecific hybrid mice.
Nagase H; Mao JH; Balmain A
Cancer Res; 2003 Aug; 63(16):4849-53. PubMed ID: 12941805
[TBL] [Abstract][Full Text] [Related]
16. Allelotype analysis of 2',3'-dideoxycytidine- and 1,3-butadiene-induced lymphomas in B6C3F1 mice.
Zhuang SM; Eklund LK; Cochran C; Rao GN; Wiseman RW; Söderkvist P
Cancer Res; 1996 Jul; 56(14):3338-43. PubMed ID: 8764131
[TBL] [Abstract][Full Text] [Related]
17. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA
Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761
[TBL] [Abstract][Full Text] [Related]
18. Step-wise progression in human skin carcinogenesis in vitro involves mutational inactivation of p53, rasH oncogene activation and additional chromosome loss.
Boukamp P; Peter W; Pascheberg U; Altmeier S; Fasching C; Stanbridge EJ; Fusenig NE
Oncogene; 1995 Sep; 11(5):961-9. PubMed ID: 7675455
[TBL] [Abstract][Full Text] [Related]
19. Analysis of chromosome 17p13 (p53 locus) alterations in gastric carcinoma cells by dual-color fluorescence in situ hybridization.
Kobayashi M; Kawashima A; Mai M; Ooi A
Am J Pathol; 1996 Nov; 149(5):1575-84. PubMed ID: 8909247
[TBL] [Abstract][Full Text] [Related]
20. Genetic changes during mouse skin tumorigenesis.
Burns PA; Bremner R; Balmain A
Environ Health Perspect; 1991 Jun; 93():41-4. PubMed ID: 1685445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
